My suggestion for multidisciplinary research into the toxicology of vomitoxin is as follows:
The current levels of concern for VT have largely been established by extrapolation from animal toxicology studies in the absence of a clear understanding of the mechanism of action of this mycotoxin in different species. At Michigan State, we are developing an extensive understanding of how VT and other trichothecenes work at the cellular and molecular level using rodent models and cells derived from rodents. Certain transcription factors controlling immune system cytokines appear to be particularly susceptible to these effects. These highly sensitive approaches allow us to accurately identify the "no effect levels" of VT for this experimental species.
We now need to extend this work to other species including humans and food-producing animals. We specifically propose to assess effects of VT on the above endpoints in : (1) swine(a known sensitive animal species), (2) cell cultures from swine, and (3)cell cultures from humans. By relating in vitro and in vivo animal data to human in vitro data, we should be able to make a more intelligent extrapolation of the potential effects of VT on humans. This information will be of economic importance should changes in the current FDA level of concern be proposed or if importing countries begin to establish tolerance levels.
We have the expertise at MSU National Food Safety and Toxicology Center to conduct this research.
Jim Pestka Dept. of Fod Science and Human Nutrition Michigan State University